Form 4: Guardant Health Executive Terilyn J. Monroe Reports Stock Option and Restricted Stock Unit Awards

Chief People Officer Terilyn J. Monroe of Guardant Health, Inc. reports the acquisition of stock options and restricted stock units.

Summary

• Terilyn J. Monroe, Chief People Officer of Guardant Health, Inc., filed a Form 4 on March 13, 2025.
• The filing reports the grant of stock options and restricted stock units on March 12, 2025.
• Monroe was granted stock options for 24,363 shares at an exercise price of $43.10.
• These options vest over a three-year period, with 33% vesting on April 1, 2026, and the remaining 67% vesting in equal monthly installments over the subsequent two years.
• Additionally, Monroe received 16,242 restricted stock units (RSUs) that also vest over a three-year period.
• 33% of the RSUs vest on April 1, 2026, and the remaining 67% vest in equal quarterly installments over the following two years.
• Following these transactions, Monroe directly holds 24,363 stock options and 16,242 restricted stock units.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a routine disclosure of executive compensation. The grants themselves are a positive sign of incentivizing management, but the disclosure is simply factual.

Positives

• The grant of stock options and RSUs to a key executive like the Chief People Officer suggests an incentive alignment with the company's long-term performance.

Industry Context

Stock option and RSU grants are common practice in the biotech industry to incentivize and retain key personnel. The vesting schedules are typical for such awards.

Comparison to Industry Standards

• Stock option and RSU grants are standard compensation tools in the biotechnology industry, used by companies like Illumina, Roche, and Exact Sciences to attract and retain talent.
• Vesting schedules of three years with a one-year cliff (initial vesting date) are also common.
• The specific number of shares and exercise price would need to be compared to similar roles and company sizes to determine if they are in line with industry benchmarks.

Stakeholder Impact

• The grants incentivize the Chief People Officer to contribute to the company's success, which could benefit shareholders.
• Employees may view the grants as a positive sign of the company's commitment to its leadership.

Key Dates